Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

49.08
Delayed Data
As of Jun 23
 -0.19 / -0.39%
Today’s Change
36.76
Today|||52-Week Range
49.59
+27.78%
Year-to-Date

Today’s Trading

Previous close49.27
Today’s open49.18
Day’s range48.97 - 49.36
Volume9,343,863
Average volume (3 months)7,041,954
Market cap$85.2B
Dividend yield2.16%
Data as of 4:00pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-47.25%
Earnings growth (this year)+12.45%
Earnings growth (next 5 years)+10.95%
Revenue growth (last year)+2.20%
P/E ratio55.1
Price/Sales2.73
Price/Book3.52

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk+0.77+1.76%
AGNAllergan-0.65-0.26%
AZNAstraZeneca-0.29-0.82%
LLYEli Lilly and Co-0.42-0.50%
Data as of 4:03pm ET, 06/23/2017

Financials

Next reporting dateJuly 19, 2017
EPS forecast (this quarter)$0.61
Annual revenue (last year)$20.9B
Annual profit (last year)$1.4B
Net profit margin5.06%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
Executive VP-Finance
Brian B. Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts